# Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies

> **NCT04335383** · — · RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 30 (estimated)

## Conditions studied

- Pseudomonas Aeruginosa
- Multi-antibiotic Resistance

## Interventions

- **BIOLOGICAL:** Isolation of anti-Pseudomonas antibodies from type B lymphocytes

## Key facts

- **NCT ID:** NCT04335383
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-05
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04335383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04335383, "Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04335383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*